Skyepharma Competitors and Similar CompaniesClear all
Skyepharma's competitors and similar companies include Avid Bioservices, Zogenix, Amicus Therapeutics and Societal CDMO.
 Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. |  Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. | ||
Founding Date | Founding Date 1996 | Founding Date 1981 | Founding Date 2006 | Founding Date 2002 | Founding Date 2006 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Saint-Quentin-Fallavier, FR HQ | Locations Tustin, US HQ | Locations Emeryville, US HQ Maidenhead, GB | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Gainesville, US HQ Gainesville, US San Diego, US |
Employees | Employees 2272% increase | Employees 21114% increase | Employees 763% increase | Employees 58415% increase | Employees 21316% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 649.4 m | Valuation ($) N/A | Valuation ($) 3.4 b | Valuation ($) 116.1 m |
Financial | |||||
Revenue (est.) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) $139.9m (FY, 2024) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $528.3m (FY, 2024) | Revenue (est.) $94.6m (FY, 2023) |
Cost of goods | Cost of goods £43.1m (FY, 2015) | Cost of goods $132.6m (FY, 2024) | Cost of goods $4.8m (FY, 2021) | Cost of goods $52.9m (FY, 2024) | Cost of goods $76.5m (FY, 2023) |
Gross profit | Gross profit £52.8m (FY, 2015) | Gross profit $7.3m (FY, 2024) | Gross profit N/A | Gross profit $475.4m (FY, 2024) | Gross profit N/A |
Net income | Net income N/A | Net income ($140.8m) (FY, 2024) | Net income ($227.4m) (FY, 2021) | Net income ($56.1m) (FY, 2024) | Net income ($13.3m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Avid Bioservices
HQ
Tustin, US
Employees
211↑ 14% increase
Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
View companyZogenix
HQ
Emeryville, US
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View companyAmicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View companySocietal CDMO
HQ
Gainesville, US
Employees
213↓ 16% decrease
Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
View company